HITAP: มูลนิธิเพื่อการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ Documents

11th HTAsiaLink Newsletter: HIGH-COST DRUGS

Change is good. Health Technology Assessment itself is constituted of many change components starting from research, which is looking for evidence to ...Read more

7 March 2019 | 168

Visit by Delegation from Ministry of Health, Chhattisgarh State, India to Learn about UHC Implementation and Challenges in Thailand

In January 2019, the Minister of Health from Chhattisgarh state, India, reached out to International Health Policy Program (IHPP), a semi-autonomous r ...Read more

5 March 2019 | 439

WORKSHOP ON HEALTH TECHNOLOGY ASSESSMENT AND USE IN HEALTH POLICY DEVELOPMENT IN VIETNAM

This visit is a part of the project to support the development of health technology assessment (HTA) in Vietnam, under the auspices of the Internation ...Read more

14 February 2019 | 486

Summary of the Stakeholder Consultation Meeting for Health Technology Assessment (HTA) Process Guideline and Follow-Up Discussion on the Progress of HTA Guidelines in Vietnam

Vietnam has decided to incorporate Health Technology Assessment (HTA) evidence to support reimbursement decisions for medicines and has recognised the ...Read more

14 February 2019 | 515

Policy Brief (Issue 15): Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?

Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screen ...Read more

7 February 2019 | 906

PolicyBrief (Issue 14): Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?

Cetuximab is provided for mCRC patients with positive KRAS wild type, and also head and neck cancer patients as indicated in the Indonesian National D ...Read more

7 February 2019 | 779

ต้องการข้อมูลเพิ่มเติม ติดต่อฝ่ายสื่อสารองค์กร HITAP

« Previous
1
…
25
26
27
28
29
…
59
Next »

11th HTAsiaLink Newsletter: HIGH-COST DRUGS

Visit by Delegation from Ministry of Health, Chhattisgarh State, India to Learn about UHC Implementation and Challenges in Thailand

WORKSHOP ON HEALTH TECHNOLOGY ASSESSMENT AND USE IN HEALTH POLICY DEVELOPMENT IN VIETNAM

Summary of the Stakeholder Consultation Meeting for Health Technology Assessment (HTA) Process Guideline and Follow-Up Discussion on the Progress of HTA Guidelines in Vietnam

Policy Brief (Issue 15): Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?

PolicyBrief (Issue 14): Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?

Cost analysis of stigmatization and discrimination reduction package in health care settings

Policy Brief (Issue 13): Promoting Healthcare Quality for Effective UHC: Thailand’s Trajectory

Policy Brief (Issue 12): Primary Health Care: the building block of Universal Health Coverage

Policy Brief (Issue 11): Health Management Information Systems for Universal Health Coverage

Blog: Most Viewed

Follow Us on Twitter

Recent Posts

Categories

Archives

Menu

Follow Us On

Subscribe to our mailing list

HITAP เข้าสู่ระบบ

Blog: Most Viewed

Follow Us on Twitter

Recent Posts

Categories

Archives

Tags

Menu

Follow Us On

Subscribe to our mailing list

Subscribe to our mailing list